Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hyuk Jean Kwon
Institutions:
The University of Texas MD Anderson Cancer Center,
The University of Texas Health Science Center at Houston
Observed institutions:
The University of Texas MD Anderson Cancer Center,
Johns Hopkins University,
Johns Hopkins Medicine,
Johns Hopkins Hospital,
The University of Texas Health Science Center at Houston
ORCID:
0009-0000-7055-0014
Observed ORCID:
0009-0000-7055-0014
OpenAlex ID:
A5058014192
DPY30 Is an Epigenetic Decoupler Linking Replication Stress to Immunoediting in Pancreatic Cancer
2026
·
Francesca Citron
, Luca Cecchetto
, et al.
·
Cancer Research
·
2
Figure S3 from DPY30 Is an Epigenetic Decoupler Linking Replication Stress to Immunoediting in Pancreatic Cancer
2026
·
Francesca Citron
, Luca Cecchetto
, et al.
Table S4 from DPY30 Is an Epigenetic Decoupler Linking Replication Stress to Immunoediting in Pancreatic Cancer
2026
·
Francesca Citron
, Luca Cecchetto
, et al.
Figure S6 from DPY30 Is an Epigenetic Decoupler Linking Replication Stress to Immunoediting in Pancreatic Cancer
2026
·
Francesca Citron
, Luca Cecchetto
, et al.
Data from DPY30 Is an Epigenetic Decoupler Linking Replication Stress to Immunoediting in Pancreatic Cancer
2026
·
Francesca Citron
, Luca Cecchetto
, et al.
Table S3 from DPY30 Is an Epigenetic Decoupler Linking Replication Stress to Immunoediting in Pancreatic Cancer
2026
·
Francesca Citron
, Luca Cecchetto
, et al.
Table S1 from DPY30 Is an Epigenetic Decoupler Linking Replication Stress to Immunoediting in Pancreatic Cancer
2026
·
Francesca Citron
, Luca Cecchetto
, et al.
Figure S8 from DPY30 Is an Epigenetic Decoupler Linking Replication Stress to Immunoediting in Pancreatic Cancer
2026
·
Francesca Citron
, Luca Cecchetto
, et al.
Figure S7 from DPY30 Is an Epigenetic Decoupler Linking Replication Stress to Immunoediting in Pancreatic Cancer
2026
·
Francesca Citron
, Luca Cecchetto
, et al.
Figure S5 from DPY30 Is an Epigenetic Decoupler Linking Replication Stress to Immunoediting in Pancreatic Cancer
2026
·
Francesca Citron
, Luca Cecchetto
, et al.
Figure S1 from DPY30 Is an Epigenetic Decoupler Linking Replication Stress to Immunoediting in Pancreatic Cancer
2026
·
Francesca Citron
, Luca Cecchetto
, et al.
Table S2 from DPY30 Is an Epigenetic Decoupler Linking Replication Stress to Immunoediting in Pancreatic Cancer
2026
·
Francesca Citron
, Luca Cecchetto
, et al.
Figure S2 from DPY30 Is an Epigenetic Decoupler Linking Replication Stress to Immunoediting in Pancreatic Cancer
2026
·
Francesca Citron
, Luca Cecchetto
, et al.
Figure S4 from DPY30 Is an Epigenetic Decoupler Linking Replication Stress to Immunoediting in Pancreatic Cancer
2026
·
Francesca Citron
, Luca Cecchetto
, et al.
Abstract 6803: Targeting mitochondrial complex I overcomes adaptive response to chemotherapy in advanced pancreatic cancer
2026
·
Sergio Attanasio
, Francesca Citron
, et al.
·
Cancer Research
Supplementary Figure 13 from GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic Adenocarcinoma
2026
·
Ziheng Chen
, I-Lin Ho
, et al.
Supplementary Figure 4 from GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic Adenocarcinoma
2026
·
Ziheng Chen
, I-Lin Ho
, et al.
Supplementary Figure 1 from GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic Adenocarcinoma
2026
·
Ziheng Chen
, I-Lin Ho
, et al.
Supplementary Figure 8 from GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic Adenocarcinoma
2026
·
Ziheng Chen
, I-Lin Ho
, et al.
Data from GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic Adenocarcinoma
2026
·
Ziheng Chen
, I-Lin Ho
, et al.
Supplementary Figure 10 from GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic Adenocarcinoma
2026
·
Ziheng Chen
, I-Lin Ho
, et al.
Supplementary Figure 7 from GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic Adenocarcinoma
2026
·
Ziheng Chen
, I-Lin Ho
, et al.
Supplementary Figure 6 from GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic Adenocarcinoma
2026
·
Ziheng Chen
, I-Lin Ho
, et al.
Supplementary Figure 5 from GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic Adenocarcinoma
2026
·
Ziheng Chen
, I-Lin Ho
, et al.
Supplementary Figure 11 from GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic Adenocarcinoma
2026
·
Ziheng Chen
, I-Lin Ho
, et al.
Show more works
View as search
Works count:
35
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type